UK AI drug safety startup Sable Bio raises €3.15 million; plans to grow its London team
Sable Bio, a London-based AI drug safety startup, today announced that it has raised €3.2 million in Seed funding to scale its platform. The round was led by MMC Ventures, with participation from existing investors Episode 1 Ventures and Seedcamp. “The …